Literature DB >> 5508406

Clinical comparison of inhaled terbutaline and orciprenaline in asthmatic patients.

H Formgren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5508406

Source DB:  PubMed          Journal:  Scand J Respir Dis        ISSN: 0036-5572


× No keyword cloud information.
  8 in total

1.  Terbutaline in children with asthma.

Authors:  J Leegaard; S Fjulsrud
Journal:  Arch Dis Child       Date:  1973-03       Impact factor: 3.791

2.  Effects of a new stimulator of beta-receptors, terbutaline, on ventilatory capacity, lung resistance, heart rate and blood pressure.

Authors:  B Elgefors; L Wilhelmsen
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

3.  An economical method of comparing inhaled bronchodilators in reversible diffuse airways obstruction. With special reference to a beta-2 stimulant--salmefamol.

Authors:  S Lal; C H Dash; M D Gribben
Journal:  Thorax       Date:  1974-05       Impact factor: 9.139

4.  Terbutaline: a preliminary report of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

5.  The effects of salbutamol and terbutaline on physiological tremor, bronchial tone and heart rate.

Authors:  J M Watson; A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

Review 6.  Drug therapy approaches in the treatment of acute severe asthma in hospitalised children.

Authors:  L K DeNicola; M O Gayle; K V Blake
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

7.  Trial of new bronchodilator, terbutaline, in asthma.

Authors:  B J Freedman
Journal:  Br Med J       Date:  1971-03-20

8.  Terbutaline metered-dose inhalation vs metaproterenol by hand-held nebulization: a comparison in black inner-city COPD patients.

Authors:  A B Greene; C L Jackson
Journal:  J Natl Med Assoc       Date:  1988-04       Impact factor: 1.798

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.